The potential of probiotics and prebiotics for skin health

Textbook of Aging Skin

Volumn , Issue , 2010, Pages 799-809

  Ouwehand, Arthur C ^a   Tiihonen, Kirsti ^a   Lahtinen, Sampo ^a  

^a Danisco Finland Oy   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84886918911     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-89656-2_77     Document Type: Chapter

References (34)

1. Guidelines for the evaluation of probiotics in food. http://www.who. int/foodsafety/publications/fs-management/probiotics2/en/: 2002.
2. Ouwehand AC, Mäkeläinen H, Tiihonen K, Rautonen N. Digestive health. In: Mitchell H (ed) Sweeteners and Sugar Alternatives in Food Technology. Oxford: Blackwell, 2006, pp. 44-53.
3. Warskulat U, Flogel U, Jacoby C, Hartwig HG, Thewissen M, Merx MW, et al. Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised. FASEB J. 2004;18(3):577-579.
4. Gao Z, Tseng CH, Pei Z, Blaser MJ. Molecular analysis of human forearm superficial skin bacterial biota. Proc Natl Acad Sci USA. 2007;104(8):2927-2932.
5. Grice EA, Kong HH, Renaud G, Young AC, Bouffard GG, Blakesley RW, et al. A diversity profile of the human skin microbiota. Genome Res. 2008;18(7):1043-1050.
6. Gao Z, Tseng CH, Strober BE, Pei Z, Blaser MJ. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS ONE. 2008;3(7):e2719.
7. Paulino LC, Tseng CH, Strober BE, Blaser MJ. Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions. J Clin Microbiol. 2006;44(8):2933-2941.
8. Dekio I, Hayashi H, Sakamoto M, Kitahara M, Nishikawa T, Suematsu M, et al. Detection of potentially novel bacterial components of the human skin microbiota using culture-independent molecular profiling. J Med Microbiol. 2005;54(Pt 12): 1231-1238.
9. Bek-Thomsen M, Lomholt HB, Kilian M. Acne is not associated with yet-uncultured bacteria. J Clin Microbiol. 2008;46(10):3355-3360.
10. Dekio I, Sakamoto M, Hayashi H, Amagai M, Suematsu M, Benno Y. Characterization of skin microbiota in patients with atopic dermatitis and in normal subjects using 16S rRNA gene-based comprehensive analysis. J Med Microbiol. 2007;56(Pt 12):1675-1683.
11. Cinque B, Di Marzio L, Della Riccia DN, Bizzini F, Giuliani M, Fanini D, et al. Effect of Bifidobacterium infantis on Interferongamma-induced keratinocyte apoptosis: A potential therapeutic approach to skin immune abnormalities. Int J Immunopathol Pharmacol. 2006;19(4):775-786.
12. Ouwehand A, Lahtinen S, Nurminen P. Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019. In: Lee YK, Salminen S (eds) Handbook of Probiotics and Prebiotics. Hoboken:Wiley, 2009, pp. 473-477.
13. Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol. 2008;121(1):116-121.
14. Chapat L, Chemin K, Dubois B, Bourdet-Sicard R, Kaiserlian D. Lactobacillus casei reduces CD8+ T cell-mediated skin inflammation. Eur J Immunol. 2004;34(9):2520-2528.
15. Watanabe J, Sasajima N, Aramaki A, Sonoyama K. Consumption of fructo-oligosaccharide reduces 2, 4-dinitrofluorobenzene-induced contact hypersensitivity in mice. Br J Nutr. 2008;100(2):339-346.
16. Peguet-Navarro J, Dezutter-Dambuyant C, Buetler T, Leclaire J, Smola H, Blum S. et al. Supplementation with oral probiotic bacteria protects human cutaneous immune homeostasis after UVexposuredouble blind, randomized, placebo controlled clinical trial. Eur J Dermatol. 2008;18(5):504-511.
17. Baba H, Masuyama A, Takano T. Effects of Lactobacillus helveticusfermented milk on the differentiation of cultured normal human epidermal keratinocytes. J Dairy Sci. 2006;89(6):2072-2075.
18. Miyazaki K, Hanamizu T, Iizuka R, Chiba K. Bifidobacteriumfermented soy milk extract stimulates hyaluronic acid production in human skin cells and hairless mouse skin. Skin Pharmacol Appl Skin Physiol. 2003;16(2):108-116.
19. Ouwehand AC, Salminen S. The health effects of cultured milk products with viable and non-viable bacteria. Int Dairy J. 1998;8:749-758.
20. Valdez JC, Peral MC, Rachid M, Santana M, Perdigon G. Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: The potential use of probiotics in wound treatment. Clin Microbiol Infect. 2005;11(6):472-479.
21. Rodrigues KL, Caputo LR, Carvalho JC, Evangelista J, Schneedorf JM. Antimicrobial and healing activity of kefir and kefiran extract. Int J Antimicrob Agents. 2005;25(5):404-408.
22. Nikitenko VI. Infection prophylaxis of gunshot wounds using probiotics. J Wound Care. 2004;13(9):363-366.
23. Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol. 2008;121(1):116-121.
24. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: A randomized placebo-controlled trial. Lancet. 2001;357:1076-1079.
25. Kopp MV, Hennemuth I, Heinzmann A, Urabanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: No clinical effects of Lactobacillus GG supplementation. Pediatrics. 2008;121(4):850-856.
26. Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M. Probiotics and prebiotic galactooligosaccharides in th eprevebtion of allergic diseases: A randomized, double-blind, placebo-controlled trail. J Allergy Clin Immunol. 2007;119(1):192-198.
27. Abrahamsson TR, Jakobsson T, Bottcher MF, Fredrikson M, Jenmalm MC, Bjorksten B, Oldaeus G. Probiotics in prevention of IgEassociated eczema: A double-blind, randomized, placebo-controlled trail. J Allergy Clin Immunol. 2007;119(5):1174-1180.
28. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: A randomized controlled trail. J Allergy Clin Immunol. 2007;119(1): 184-191.
29. Wickens K, Black PN, Stanley TV, Mitchell, Fitzharris P, Tannock GW, Purdie G, Crane J. A differential effect of 2 probiotics in the prevention of eczema and atopy: A double-blind, randomized, placebo-controlled trail. J Allergy Clin Immunol. 2008;122(4):788-794.
30. Lodinová-Zádniková R, Cukrowska B, Tlaskalová-Hogenová H. Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int Arch Allergy Immunol. 2003;131:209-211.
31. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. A mixture of prebiotic oligasaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child. 2006; 91(10):814-819
32. Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000;30: 1604-1610.
33. Brouwer ML, Wolt-plompen SA, Dubois AE, Van Der HS, Jansen DF, Hoijer MA, et al. No effects of probiotics on atopic dermatitis in infancy: A randomized placebo-controlled trail. Clin Exp Allergy. 2006;36(7):899-906.
34. Fölster-Holst R, Muller F, Schnopp N, abeck D, Kreiselmaier I, Lenz T, von Rüden U, Schrezenmeir J, Christophers E, Weichenthal M. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br J Dermatol. 2006;155(6):1256-1261.